Enanta Pharmaceuticals (ENTA) Receivables - Other (2012 - 2015)

Enanta Pharmaceuticals (ENTA) has 4 years of Receivables - Other data on file, last reported at $1.0 million in Q4 2015.

• Quarterly Receivables - Other fell 46.39% year-over-year to $1.0 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $1.0 million (down 46.39% YoY) and the FY2015 annual result came in at $433000.0, down 84.37% from the prior year.
• Receivables - Other climbed to $1.0 million in Q4 2015, from $433000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $2.8 million in Q3 2014 to a low of $433000.0 in Q3 2015.
• A 4-year average of $1.4 million and a median of $1.4 million in 2015 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2014 — Receivables - Other jumped 253.32% — and 2015, when it sank 84.37%.
• Tracing ENTA's Receivables - Other over 4 years: stood at $1.7 million in 2012, then slumped by 44.3% to $929000.0 in 2013, then jumped by 102.58% to $1.9 million in 2014, then plunged by 46.39% to $1.0 million in 2015.
• The last three Receivables - Other figures came in at $1.0 million (Q4 2015), $433000.0 (Q3 2015), and $1.4 million (Q2 2015), per Business Quant data.